Abstract

Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding

Author(s): Martin Matt

Issue: Jan/Feb 2019 - Volume 23, Number 1

Page(s): 47-49

Download in electronic PDF format for $75
  • Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding Page 1
  • Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding Page 2
  • Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding Page 3

Abstract

What do you do when something goes wrong in your cleanroom? What do you do when a sterility test fails and what are the implications of such a failure? What should you do when your environmental monitoring or personnel monitoring provides results that exceed your action levels? A root cause analysis is needed in any situation where action levels are exceeded or tests are out of specification. However, should the questions be what can be done to prevent these occurrences, and how can the development be noticed before they occur? In this article, we will discuss going beyond the recommendations of United States Pharmacopeia Chapter <797> to attempt to build a program that limits the possibility of contamination through monitoring of the facility, personnel, and procedures in aseptic processing. We will also discuss other resources published by the U.S. Food and Drug Administration that address monitoring of sterile compounding and aseptic processing.

Related Keywords

  • out of specification results
  • root cause analysis
  • sterile compounding
  • United States Pharmacopeia Chapter <797>
  • USP
  • U.S. Food and Drug Administration
  • FDA
  • pharmacy inspection
  • Guidance for Industry
  • GFI
  • drug contamination
  • Current Good Manufacturing Practice
  • CGMP
  • sterility testing
  • environmental monitoring
  • aseptic processing
  • gloving
  • gowning
  • surface sampling
  • air sampling
  • compounded sterile preparation

Related Categories

  • ENVIRONMENTAL
  • LEGAL
  • STERILE PREPARATIONS
  • QUALITY CONTROL
  • UNITED STATES PHARMACOPEIA CONVENTIONS
  • ADVERSE DRUG EVENTS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2019
Pg. 47-49
Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding
Author(s): Martin Matt
Mar/Apr 2020
Pg. 92
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 491-496
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 180
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>, <797>, and <825>: Part 2
Author(s): Allen Loyd V Jr
Mar/Apr 2021
Pg. 115-124
Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice
Author(s): Kelley Brian
Jul/Aug 2007
Pg. 302-305
Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations
Author(s): Okeke Claudia C
Sep/Oct 2008
Pg. 440-443
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 9: Immediate-Use Compounded Sterile Preparations
Author(s): Allen Loyd V Jr, Okeke Claudia C
Sep/Oct 2007
Pg. 404-410
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels
Author(s): Allen Loyd V Jr, Okeke Claudia C
Jan/Feb 2006
Pg. 41-42
Quality Control Analytical Methods: Common Concerns about Out-of-Specification Results
Author(s): Lanier Lance, Kemp Jesse
May/Jun 2009
Pg. 234-238
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 13: Environmental Quality and Control
Author(s): Allen Loyd V Jr, Okeke Claudia C
Mar/Apr 2008
Pg. 136-144
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797>
Author(s): Allen Loyd V Jr, Okeke Claudia C
Mar/Apr 2016
Pg. 99-104
Root Cause Analysis, Part 2: Sterile Compounding
Author(s): Cabaleiro Joe, Jackson Kathleen
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jul/Aug 2009
Pg. 322-329
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 14: Environmental Quality and Control (Continued)
Author(s): Okeke Claudia C, Allen Loyd V Jr
Jul/Aug 2010
Pg. 328-331
Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program
Author(s): Okeke Claudia C, Allen Loyd V Jr
Jul/Aug 2004
Pg. 251-263
A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards
Author(s): Newton David W, Trissel Lawrence A
Mar/Apr 2005
Pg. 127-130
Proposed Revisions to USP Chapter <797> Pharmaceutical Compounding--Sterile Preparations
Author(s): Newton David W
Jul/Aug 2007
Pg. 314-323
Basics of Compounding: The Responsibilities of Compounding Personnel in Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 2
Author(s): Allen Loyd V Jr, Okeke Claudia C
Sep/Oct 2018
Pg. 401-404
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1
Author(s): Martin Matt
May/Jun 2007
Pg. 230-236
Basics of Compounding for the Implementation of United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 1
Author(s): Allen Loyd V Jr, Okeke Claudia C